BioPharma Credit PLC declare an interim dividend in respect of the financial period ended 30 September 2023 of $0.0375 per ordinary share, payable on 5 January 2024 to ordinary shareholders on the register as at 8 December 2023. The ex-dividend date will be 7 December 2023. The $0.0375 dividend comprises an ordinary dividend of $0.0175 and a special dividend of $0.0200The Company is currently paying and continues to target a 7 cent annual dividend per ordinary share.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.88 USD | -0.23% | -0.45% | +4.76% |
May. 02 | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
May. 02 | BioPharma Credit agrees USD400 million loan for oncology firm Novacure | AN |
1st Jan change | Capi. | |
---|---|---|
+4.76% | 1.08B | |
+3.74% | 12.64B | |
+12.28% | 9.62B | |
+10.01% | 5.62B | |
-2.85% | 5.43B | |
+8.47% | 5.32B | |
+14.23% | 4.47B | |
+16.04% | 4.43B | |
+2.17% | 4.07B | |
+8.24% | 3.92B |
- Stock Market
- Equities
- BPCR Stock
- News BioPharma Credit PLC
- BioPharma Credit PLC Declares Interim Dividend in Respect of the Financial Period Ended 30 September 2023, Payable on 5 January 2024